Publication | Closed Access

PEGylated liposomes as an emerging therapeutic platform for oral nanomedicine in cancer therapy: in vitro and in vivo assessment

NanoparticlesNanomedicineEngineeringTherapeutic NanomaterialsMedicineVivo AssessmentPharmaceutical NanotechnologyNano-drug DeliveryTumor TargetingBiomedical EngineeringOral NanomedicinePharmacologyRadiation OncologyTumor MicroenvironmentTherapeutic Platform